{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:34:44Z","timestamp":1782135284413,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.clgc.2019.06.010","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T22:38:59Z","timestamp":1561502339000},"page":"380-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Reviewing the Demographic, Prognostic, and Treatment Factors of Primary Adenocarcinoma of the Bladder: A SEER Population-based Study"],"prefix":"10.1016","volume":"17","author":[{"given":"Caleb","family":"Natale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Z.","family":"Leinwand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Silberstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5620-7698","authenticated-orcid":false,"given":"L. Spencer","family":"Krane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2019.06.010_bib1","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0302-2838(03)00416-0","article-title":"Malignant non-urothelial neoplasms of the urinary bladder: a review","volume":"44","author":"Dahm","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2019.06.010_bib2","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/1097-0142(19910415)67:8<2165::AID-CNCR2820670827>3.0.CO;2-M","article-title":"Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases","volume":"67","author":"Grignon","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2019.06.010_bib3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.5858\/arpa.2012-0076-RA","article-title":"Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance","volume":"137","author":"Zhong","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clgc.2019.06.010_bib4","series-title":"Biopsy Interpretation of the Bladder","first-page":"180","article-title":"Glandular lesions","author":"Epstein","year":"2010"},{"key":"10.1016\/j.clgc.2019.06.010_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1464-410X.1998.00718.x","article-title":"Primary adenocarcinoma of the urinary bladder: a report of 185 cases","volume":"82","author":"el-Mekresh","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.clgc.2019.06.010_bib6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.urology.2009.10.018","article-title":"Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality","volume":"75","author":"Lughezzani","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2019.06.010_bib7","doi-asserted-by":"crossref","first-page":"531.e1","DOI":"10.1016\/j.urolonc.2016.06.009","article-title":"Effect of tumor location on survival in urinary bladder adenocarcinoma: a population-based analysis","volume":"34","author":"Dutta","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2019.06.010_bib8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/1097-0142(19831001)52:7<1273::AID-CNCR2820520724>3.0.CO;2-7","article-title":"Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study","volume":"52","author":"Anderstr\u00f6m","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2019.06.010_bib9","first-page":"51","article-title":"Adenocarcinoma of the urinary bladder","volume":"3","author":"Dadhania","year":"2015","journal-title":"Am J Clin Exp Urol"},{"key":"10.1016\/j.clgc.2019.06.010_bib10","doi-asserted-by":"crossref","first-page":"33.e11","DOI":"10.1016\/j.urolonc.2016.07.021","article-title":"Malignant urachal neoplasms: a population-based study and systematic review of literature","volume":"35","author":"Mylonas","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2019.06.010_bib11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/cncr.22059","article-title":"Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder","volume":"107","author":"Wright","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2019.06.010_bib12","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1158\/1078-0432.CCR-10-2770","article-title":"New strategies in muscle-invasive bladder cancer: on the road to personalized medicine","volume":"17","author":"Shah","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2019.06.010_bib13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/MOU.0000000000000089","article-title":"Variant histology: role in management and prognosis of nonmuscle invasive bladder cancer","volume":"24","author":"Porten","year":"2014","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.clgc.2019.06.010_bib14","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1016\/j.clgc.2015.04.002","article-title":"A\u00a0case of advanced mucinous adenocarcinoma of bladder in an adult patient treated with capecitabine-based chemotherapy and review of literature","volume":"13","author":"Messina","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2019.06.010_bib15","first-page":"1295","article-title":"Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience","volume":"169","author":"Siefker-Radtke","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2019.06.010_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.urology.2006.10.029","article-title":"Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract","volume":"69","author":"Galsky","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2019.06.010_bib17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12032-008-9106-7","article-title":"Palliative chemotherapy for non-transitional cell carcinomas of the urothelial tract","volume":"26","author":"Hong","year":"2009","journal-title":"Med Oncol"},{"key":"10.1016\/j.clgc.2019.06.010_bib18","first-page":"1494","article-title":"Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort","volume":"161","author":"Bassi","year":"1999","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2019.06.010_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.23162","article-title":"Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy","volume":"112","author":"Shariat","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2019.06.010_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0090-4295(93)90239-7","article-title":"Signet-ring cell adenocarcinoma of bladder","volume":"41","author":"Fiter","year":"1993","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2019.06.010_bib21","first-page":"927","article-title":"Signet-ring cell carcinoma of urachus: a case report and review of literature","volume":"43","author":"Ravi","year":"1990","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.clgc.2019.06.010_bib22","first-page":"203","article-title":"Signet ring cell adenocarcinoma of the bladder: linitis plastica variant","volume":"105","author":"Poore","year":"1981","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clgc.2019.06.010_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.urolonc.2005.05.027","article-title":"Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients","volume":"24","author":"Zaghloul","year":"2006","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2019.06.010_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MOU.0b013e328363e415","article-title":"Should histologic variants alter definitive treatment of bladder cancer?","volume":"23","author":"Willis","year":"2013","journal-title":"Curr Opin Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767319301995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767319301995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:32:04Z","timestamp":1761564724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767319301995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1558767319301995"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2019.06.010","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reviewing the Demographic, Prognostic, and Treatment Factors of Primary Adenocarcinoma of the Bladder: A SEER Population-based Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2019.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}